Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.

about

Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.

Item

http://www.wikidata.org/entity/Q36127289

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@ast

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@en

type

Item

label

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@ast

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@en

prefLabel

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@ast

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@en

P1476

Structural and Functional Outc ...... ted with Photodynamic Therapy.

@en

P2093

Eugenia González

http://www.w3.org/2001/XMLSchema#string

Jesús García

http://www.w3.org/2001/XMLSchema#string

Mónica Asencio

http://www.w3.org/2001/XMLSchema#string

Pino Cidad

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term follow-up of central serous retinopathy in 150 patients.

Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.

Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.

Factors influencing the visual acuity of chronic central serous chorioretinopathy

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.

Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report.

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy

Cystoid macular degeneration in chronic central serous chorioretinopathy.

P304

331-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3341/KJO.2015.29.5.331

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282448912

http://www.w3.org/2001/XMLSchema#string

P698

26457039

http://www.w3.org/2001/XMLSchema#string

P932

4595259

http://www.w3.org/2001/XMLSchema#string